Characterization of Scardovia wiggsiae Biofilm by Original Scanning Electron Microscopy Protocol

• Published in: Microorganisms (Basel) 2020-05, Vol.8 (6), p.807
• Main Authors: Bossù, Maurizio, Selan, Laura, Artini, Marco, Relucenti, Michela, Familiari, Giuseppe, Papa, Rosanna, Vrenna, Gianluca, Spigaglia, Patrizia, Barbanti, Fabrizio, Salucci, Alessandro, Giorgio, Gianni Di, Rau, Julietta V, Polimeni, Antonella
• Format: Article
• Language: English
• Subjects: Actinomycetes; biofilm; early childhood caries; Health aspects; Identification and classification; microbiota; pediatric dentistry; Scardovia wiggsiae; Streptococcus mutans scanning electron microscopy
• ISSN: 2076-2607; 2076-2607
• DOI: 10.3390/microorganisms8060807

Early childhood caries (ECC) is a severe manifestation of carious pathology with rapid and disruptive progression. The ECC microbiota includes a wide variety of bacterial species, among which is an anaerobic newly named species, a previously unidentified . Our aim was to provide the first ultrastructural characterization of and its biofilm by scanning electron microscopy (SEM) using a protocol that faithfully preserved the biofilm architecture and allowed an investigation at very high magnifications (order of nanometers) and with the appropriate resolution. To accomplish this task, we analyzed ' biofilm by conventional SEM and VP-SEM protocols, in addition, we developed an original procedure, named OsO -RR-TA-IL, which avoids dehydration, drying and sputter coating. This innovative protocol allowed high-resolution and high-magnification imaging (from 10000× to 35000×) in high-vacuum and high-voltage conditions. After comparing three methods, we chose OsO -RR-TA-IL to investigate . It appeared as a fusiform elongated bacterium, without surface specialization, arranged in clusters and submerged in a rich biofilm matrix, which showed a well-developed micro-canalicular system. Our results provide the basis for the development of innovative strategies to quantify the effects of different treatments, in order to establish the best option to counteract ECC in pediatric patients.